Goldman Sachs Group Inc Ironwood Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,223,137 shares of IRWD stock, worth $5.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,223,137
Previous 1,563,432 21.77%
Holding current value
$5.61 Million
Previous $10.2 Million 50.68%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.93 - $7.04 $1.34 Million - $2.4 Million
-340,295 Reduced 21.77%
1,223,137 $5.03 Million
Q2 2024

Aug 13, 2024
BUY
$5.58 - $8.61 $1.03 Million - $1.58 Million
183,770 Added 13.32%
1,563,432 $10.2 Million
Q1 2024

May 15, 2024
BUY
$8.32 - $15.45 $2.48 Million - $4.6 Million
297,997 Added 27.55%
1,379,662 $12 Million
Q4 2023

Feb 13, 2024
SELL
$8.79 - $11.51 $218,906 - $286,645
-24,904 Reduced 2.25%
1,081,665 $12.4 Million
Q3 2023

May 14, 2024
BUY
$8.25 - $11.35 $205,458 - $282,660
24,904 Added 2.3%
1,106,569 $10.7 Million
Q3 2023

Nov 14, 2023
BUY
$8.25 - $11.35 $924,866 - $1.27 Million
112,105 Added 11.27%
1,106,569 $10.7 Million
Q2 2023

May 14, 2024
SELL
$10.1 - $11.6 $836,613 - $960,862
-82,833 Reduced 7.69%
994,464 $10.6 Million
Q2 2023

Aug 14, 2023
SELL
$10.1 - $11.6 $836,613 - $960,862
-82,833 Reduced 7.69%
994,464 $10.6 Million
Q1 2023

May 14, 2024
BUY
$10.37 - $12.56 $613,582 - $743,162
59,169 Added 5.81%
1,077,297 $11.3 Million
Q1 2023

May 11, 2023
BUY
$10.37 - $12.56 $613,582 - $743,162
59,169 Added 5.81%
1,077,297 $11.3 Million
Q4 2022

May 14, 2024
SELL
$9.9 - $12.43 $3.87 Million - $4.86 Million
-390,589 Reduced 27.73%
1,018,128 $12.6 Million
Q4 2022

Feb 13, 2023
SELL
$9.9 - $12.43 $3.87 Million - $4.86 Million
-390,589 Reduced 27.73%
1,018,128 $12.6 Million
Q3 2022

May 14, 2024
BUY
$10.14 - $12.38 $4.22 Million - $5.16 Million
416,590 Added 41.99%
1,408,717 $14.6 Million
Q3 2022

Nov 10, 2022
BUY
$10.14 - $12.38 $4.22 Million - $5.16 Million
416,590 Added 41.99%
1,408,717 $14.6 Million
Q2 2022

May 14, 2024
SELL
$11.05 - $12.72 $989,394 - $1.14 Million
-89,538 Reduced 8.28%
992,127 $11.4 Million
Q2 2022

Aug 15, 2022
SELL
$11.05 - $12.72 $18 Million - $20.7 Million
-1,625,784 Reduced 62.1%
992,127 $11.4 Million
Q1 2022

May 16, 2022
SELL
$10.61 - $12.88 $7.36 Million - $8.93 Million
-693,230 Reduced 20.94%
2,617,911 $32.9 Million
Q4 2021

Feb 14, 2022
BUY
$10.86 - $13.95 $2.56 Million - $3.29 Million
235,865 Added 7.67%
3,311,141 $38.6 Million
Q3 2021

Nov 10, 2021
BUY
$11.92 - $13.92 $36.7 Million - $42.8 Million
3,075,276 New
3,075,276 $40.2 Million

Others Institutions Holding IRWD

# of Institutions
237
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $703M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email